✦ LIBER ✦

Management consensus guidance for the use of rivaroxaban – an oral, direct factor Xa inhibitor

✍ Scribed by Turpie, A. G. G.; Kreutz, R.; Llau, J.; Norrving, B.; Haas, S.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The discovery and development of rivarox

✍ Perzborn, Elisabeth; Roehrig, Susanne; Straub, Alexander; Kubitza, Dagmar; Misse 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 588 KB

Assessment of laboratory assays to measu

✍ Samama, M. M.; Martinoli, J.-L.; LeFlem, L.; Guinet, C.; Plu-Bureau, G.; Depasse 📂 Article 📅 2010 🏛 Schattauer 🌐 English ⚖ 643 KB

Rivaroxaban – an oral, direct Factor Xa

✍ Jeanine M. Walenga; Margaret Prechel; Walter P. Jeske; Debra Hoppensteadt; Jyoth 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB

The mechanism of action of rivaroxaban –

✍ Meyer Michel Samama 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 354 KB

Effects of the oral, direct factor Xa in

✍ A. HILLARP; F. BAGHAEI; I. FAGERBERG BLIXTER; K. M. GUSTAFSSON; L. STIGENDAL; M. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 251 KB

Prevention and treatment of experimental

✍ Biemond, Bart J.; Perzborn, Elisabeth; Friederich, Philip W.; Levi, Marcel; Buet 📂 Article 📅 2007 🏛 Schattauer 🌐 English ⚖ 899 KB